 |
ExeVir Bio
Last updated: August 13, 2024
Torsten Mummenbrauer, CEO
Belgium | Funding: €68.6M (+)
Website: https://exevir.com/
ExeVir Bio develops single-domain antibody-based therapies that help patients ward off viral infections.
Website: https://exevir.com/
ExeVir Bio develops single-domain antibody-based therapies that help patients ward off viral infections.
